MAZE

Maze Therapeutics, Inc. $30.37 as of 2026-11-02
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.3%
Next 1 week
+0.2%
Next 1 month
+1.6%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 7
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.74%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.71 +1.6%
$23M/day volume 67% volatility -9% 1-year -43% from ATH
52-week range · 27% of the way up · -43% from the high
$21.95$53.65

Earnings Full history →

Next report 2026-11-05 (Thursday, after close, in 2 days) · EPS est. -0.75.

Biggest pop
+2.1%
Biggest drop
-35.2%

Standard deviation of the close-to-close move over the last 6 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-11 miss -0.70 -0.76 -9.2% +0.6% +0.8% +8.9%
2026-03-25 beat -0.69 -0.65 +5.7% -18.4% -35.2% -40.7%
2025-11-06 beat -0.69 -0.66 +4.7% +0.8% -3.5% +9.8%
2025-08-12 beat -1.15 -0.77 +33.3% +1.9% -1.0% -1.9%
2025-05-14 miss -0.63 -1.15 -83.6% -2.5% +2.1% +12.3%
2025-03-31 miss 0.45 -18.32 -4171.1% -4.5% -3.6% -21.9%

Not investment advice.